Clinical Trial Update: Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A phase 3 clinical trial is evaluating the efficacy and safety of semaglutide (Ozempic) in patients with Type 2 diabetes; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)
• semaglutide (semaglutide)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Type 2 Diabetes (T2DM) | Phase 3 | Status: NOT_YET_RECRUITING